Analytical Data
-
Gene name
EDC1
- Application
-
Alternative Names
EDC1；HCP；ITIL；Protein AMBP
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P53080
-
Expression Region
2-175aa
-
AA Sequence
STDTMYFNS SRLLPSAGRN KTNNLIKQKT RNNRARGNAA KNANNNNYIT DIPPPQTLPN GQKPNFGHSS NKKPSFNQKK HSPPSSPSST TTLGKKNRQN NKETPRQNNK DDTRLLSQNL KNLLLNQKQS PHGSQGIIPM GCNGSAKKLS HSYAGSTFAT NGPREAKNLP KPSFL
-
Molecular Weight
19.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EDC1 (Epithelial-Derived Cysteine-Rich Protein 1) is a key protein involved in various cellular processes, including cell differentiation, proliferation, and response to stress. Its expression is notably observed in epithelial tissues, hinting at its potential role in maintaining tissue homeostasis and integrity. Recent studies have highlighted the importance of EDC1 in the regulation of immune responses and in the pathophysiology of several diseases, including cancer and inflammatory conditions. The ability to produce EDC1 as a recombinant protein has significant implications for research and therapeutic applications, enabling scientists to investigate its structural and functional properties in detail. Understanding the mechanisms through which EDC1 operates could lead to novel strategies for disease intervention, particularly in targeting aberrant epithelial cell functions. As such, research focusing on the recombinant expression of EDC1 is essential for elucidating its biological roles and developing potential biomolecular therapies. This research not only contributes to our understanding of epithelial biology but also paves the way for innovation in targeted treatment modalities for diseases where EDC1 is implicated.
